| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000271659.1 |
Avagacestat |
Bladder urothelial carcinoma |
0.016172447 |
Resistant |
| ENSG00000271659.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.026418264 |
Resistant |
| ENSG00000271659.1 |
Avagacestat |
Skin cutaneous melanoma |
0.020254124 |
Resistant |
